Exploitation of Biocomputational Approaches for siRNA ‐Mediated Gene Silencing of HPV : A Novel Therapeutic Strategy for Cervical Cancer
Cancer Reports · 2025
DOI: 10.1002/cnr2.70434 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Reports, 2025. Verfasst von Md Habib Ullah Masum und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Genomics and Bioinformatics, Faculty of Biotechnology and Genetic Engineering, Chattogram Veterinary and Animal Sciences University (CV…. Hauptthemen laut MEDLINE: RNA, Small Interfering, Uterine Cervical Neoplasms, Papillomavirus Infections, Human papillomavirus 16. Die Arbeit nennt 96 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
With recurrent high‐risk human papillomavirus (HPV) infections, especially HPV16 and HPV18, cervical cancer is the fourth most common disease among women. The functional alterations of the E6 and E7 proteins are essential to the oncogenic process of high‐risk HPVs and cervical cancer development.
Aims
The objective of this research is to design highly targeted and efficient small interfering RNAs (siRNAs) that target both HPV16 and HPV18, employing cutting‐edge computational approaches to enhance therapeutic potential through a systematic bioinformatics‐driven approach. Methods and Results This study utilized the i‐Score Designer to identify and evaluate four potential small interfering RNAs (siRNAs) (E6_69, E6_451, E7_66, and E7_193) based on various algorithm criteria, including Ui‐Tei, Amarzguioui, i‐Score, and Reynolds scores. Consequently, a docking analysis was conducted to elucidate the intermolecular interactions between the RNA‐induced silencing complex (RISC) proteins and the designed siRNAs. All siRNAs passed the recommended cutoff values, indicating a strong potential for gene silencing. Thermodynamic and structural analyses revealed that the designed siRNAs had favrable melting temperatures and free energies, suggesting adequate stability for effective gene silencing. Further, docking analysis demonstrated significant binding affinities and interaction profiles with the major RISC proteins (Dicer, Ago2, TRBP). The E6_69 and E7_193 significantly showed strong binding and intermolecular interactions, especially with Ago2, highlighting the potential for HPV gene silencing.
Conclusion
The study revealed the potential of the designed siRNAs in silencing the E6 and E7 genes and their therapeutic applications against HPV. Future research should focus on validating these findings across various experiments, both in vivo and in vitro, and exploring alternative delivery approaches to enhance therapeutic efficacy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Genomics and Bioinformatics, Faculty of Biotechnology and Genetic Engineering, Chattogram Veterinary and Animal Sciences University (CVASU), Bangladesh.
- Department of Pathology and Parasitology, Faculty of Veterinary Medicine, Chattogram Veterinary and Animal Sciences University (CVASU), Bangladesh.
- Department of Obstetrics and Gynecology, Chittagong Medical College Hospital, Chattogram, Bangladesh.
ORCID-Profile: Md Habib Ullah Masum
Zitieren
APA
Masum, M. H. U., Parvin, R., Heema, H. P., Akter, A., & Ferdous, J. (2025). Exploitation of Biocomputational Approaches for siRNA ‐Mediated Gene Silencing of HPV : A Novel Therapeutic Strategy for Cervical Cancer. Cancer Reports. https://doi.org/10.1002/cnr2.70434
Vancouver
Masum MHU, Parvin R, Heema HP, Akter A, Ferdous J. Exploitation of Biocomputational Approaches for siRNA ‐Mediated Gene Silencing of HPV : A Novel Therapeutic Strategy for Cervical Cancer. Cancer Reports. 2025. doi:10.1002/cnr2.70434
BibTeX
@article{Masum2025,
author = {Masum, Md Habib Ullah and Parvin, Rehana and Heema, Homaira Pervin and Akter, Aklima and Ferdous, Jannatul},
title = {Exploitation of Biocomputational Approaches for siRNA ‐Mediated Gene Silencing of HPV : A Novel Therapeutic Strategy for Cervical Cancer},
journal = {Cancer Reports},
year = {2025},
doi = {10.1002/cnr2.70434}
}
EUVIMED